AVGO 241213 177.50P (AVGO241213P177500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

AVGO241213P177500

Watchlist

0.01
-4.79-99.79%

15min DelayClose Dec 13 16:00 ET

0.05High0.01Low

Intraday

5D
Daily

News

Broadcom Joins Nvidia, Tesla in Top Stock Options as Market Cap Hits $1 Trillion
Luzi Ann SantosDec 13 14:39 ET
Trending Stocks Amid a Mixed Week for U.S. Stock Market
Seeking Alpha12:08 ET
Bulls Vs. Bears: How Long Can Broadcom Ride the AI Gravy Train?
Seeking AlphaDec 14 10:44 ET
Notable Analyst Calls This Week: AMD, Adobe and Utilities Stocks Among Top Picks
Seeking AlphaDec 14 09:37 ET
Bernstein Maintains Broadcom(AVGO.US) With Buy Rating, Raises Target Price to $250
Moomoo NewsDec 14 09:31 ET · Ratings
Wells Fargo Maintains Broadcom(AVGO.US) With Hold Rating, Raises Target Price to $230
Moomoo NewsDec 14 09:31 ET · Ratings

Comments

10xStockPicks

1 hour ago

This $2.25 Stock Soon To Turn A Profit Is Highly Likely To Be Acquired Above $10

This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...